Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1983 2
1985 2
1987 1
1988 1
1991 1
1992 1
1993 1
1994 1
1995 5
1996 5
1997 3
1998 1
2001 1
2002 1
2003 1
2005 2
2007 1
2009 1
2011 1
2015 1
2016 2
2018 2
2019 3
2020 4
2021 1
2022 4
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Cevik M, Thompson LC, Upton C, Rolla VC, Malahleha M, Mmbaga B, Ngubane N, Abu Bakar Z, Rassool M, Variava E, Dawson R, Staples S, Lalloo U, Louw C, Conradie F, Eristavi M, Samoilova A, Skornyakov SN, Ntinginya NE, Haraka F, Praygod G, Mayanja-Kizza H, Caoili J, Balanag V, Dalcolmo MP, McHugh T, Hunt R, Solanki P, Bateson A, Crook AM, Fabiane S, Timm J, Sun E, Spigelman M, Sloan DJ, Gillespie SH; SimpliciTB Consortium. Cevik M, et al. Lancet Infect Dis. 2024 Sep;24(9):1003-1014. doi: 10.1016/S1473-3099(24)00223-8. Epub 2024 May 17. Lancet Infect Dis. 2024. PMID: 38768617 Free article. Clinical Trial.
Male reproductive hormones in patients treated with pretomanid.
Boekelheide K, Olugbosi M, Nedelman J, Everitt D, Smith E, Betteridge M, Sun E, Spigelman M. Boekelheide K, et al. Among authors: nedelman j. Int J Tuberc Lung Dis. 2022 Jun 1;26(6):558-565. doi: 10.5588/ijtld.21.0654. Int J Tuberc Lung Dis. 2022. PMID: 35650700 Free PMC article.
An Exposure-Response Perspective on the Clinical Dose of Pretomanid.
Nedelman JR, Salinger DH, Subramoney V, Woolson R, Wade K, Li M, Everitt D, Mendel CM, Spigelman M. Nedelman JR, et al. Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01121-20. doi: 10.1128/AAC.01121-20. Print 2020 Dec 16. Antimicrob Agents Chemother. 2020. PMID: 33077660 Free PMC article.
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid.
Salinger DH, Subramoney V, Everitt D, Nedelman JR. Salinger DH, et al. Among authors: nedelman jr. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00907-19. doi: 10.1128/AAC.00907-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31405856 Free PMC article.
Daily Dosing for Bedaquiline in Patients with Tuberculosis.
Salinger DH, Nedelman JR, Mendel C, Spigelman M, Hermann DJ. Salinger DH, et al. Among authors: nedelman jr. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e00463-19. doi: 10.1128/AAC.00463-19. Print 2019 Nov. Antimicrob Agents Chemother. 2019. PMID: 31451504 Free PMC article.
55 results